Several studies have demonstrated that the PD-1/PD-L1 pathway is involved in autoimmune diseases mediated by T cells such as autoimmune type 1 diabetes (DMI), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Here, PDCD1 is linked to systemic lupus erythematosus.